Evonik Industries and BRAIN co-operate

(PresseBox) ( Zwingenberg, )
Evonik Industries AG, the speciality chemicals company, and BRAIN AG, the white biotechnology company, co-operate in the field of the development of novel microorganisms with unique, selective binding- and adsorption characteristics on selected surfaces.

Within the co-operation the partners pursue the joint objective of identifying and developing suitable microorganisms, which, by using their adsorption properties, will specifically introduce novel physical properties to the selected surfaces.

It is the goal of the partners to integrate the selected microorganisms into an industrial-scale. BRAIN will contribute its expertise in biotechnology, microbiology and the development of pilot processes, while Evonik shall be responsible for the technical implementation and marketing of the products. Financial terms of the collaboration or more detailed technical information are not disclosed.

"For BRAIN, the collaboration announced today is another proof of the versality and creativity of biology and especially of the microorganisms. We are glad, that leading chemical corporations use our "toolbox of nature" with the goal to increase the value of the corporation", says Dr. Holger Zinke, Chief Executive Officer of BRAIN. "We see an enormous potential for synergies in the co-operation, allowing us to combine the technologies of BRAIN with Evonik Industries' development and marketing expertise to excellent effect."
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.